Silk Fibroin‐Modified Titanium Implants for Bone Tissue Engineering: Structural Basis, Functionalization and Composite Strategies
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.70222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Jiajun Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Hospital, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: Fibroins, Titanium, Tissue Engineering, Tissue Scaffolds. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Education Commission Scientific Research Program, Tianjin Science and Technology Support Program.
Abstract (Originalsprache)
Bone scaffolds represent a common surgical approach for repairing bone defects, and the clinical demand for effective graft substitutes remains high due to the limited availability of autologous bone. Titanium (Ti) and its alloys are widely used as load‐bearing implants; however, their inherent biological inertness hinders early osteogenesis and delays osseointegration. With advances in bone tissue engineering, biofunctionalized 3D‐printed porous Ti scaffolds have emerged as a promising strategy to overcome these limitations. Among the various biomaterials investigated, silk fibroin (SF) has attracted considerable interest owing to its excellent biocompatibility, controllable biodegradability, tunable mechanical properties, and intrinsic capacity for drug loading. The integration of SF onto Ti scaffolds through coatings, hydrogels, or composite structures mitigates the biological inertness of Ti and confers additional functionalities, such as controlled drug release, osteogenic stimulation, and immunomodulation. This review summarizes the structural characteristics, drug‐delivery behavior, and degradation mechanisms of SF, and highlights current evidence on its osteogenic and anti‐inflammatory effects both in vitro and in vivo when combined with porous Ti scaffolds. Furthermore, we discuss emerging multifunctional strategies, including composite coatings incorporating hydroxyapatite, metal‐ion doping, and SF‐based hydrogel systems. Overall, this review provides comprehensive insights into SF‐enhanced Ti scaffolds for next‐generation bone repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Hospital, Tianjin University, Tianjin, China.
- Tianjin Orthopedic Institute, Tianjin, China.
- Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering, Tianjin, China.
- Tianjin Institute of Medical and Pharmaceutical Sciences, Tianjin, China.
- Department of Rehabilitation, Tianjin University Huanhu Hospital, Tianjin, China.
- Department of Anesthesiology, Central Hospital, Tianjin University, Tianjin, China.
ORCID-Profile: Jiajun Liu
Förderung
- National Natural Science Foundation of China
- Tianjin Education Commission Scientific Research Program
- Tianjin Science and Technology Support Program
Zitieren
APA
Liu, J., Wang, Y., Li, X., Li, G., Zheng, Z., Zhang, L., Feng, X., Ma, T., Chen, Y., Li, Y., Liu, Y., Dong, B., Yang, P., Li, Y., Qin, M., & Ma, J. (2026). Silk Fibroin‐Modified Titanium Implants for Bone Tissue Engineering: Structural Basis, Functionalization and Composite Strategies. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70222
Vancouver
Liu J, Wang Y, Li X, Li G, Zheng Z, Zhang L, et al. Silk Fibroin‐Modified Titanium Implants for Bone Tissue Engineering: Structural Basis, Functionalization and Composite Strategies. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70222
BibTeX
@article{Liu2026,
author = {Liu, Jiajun and Wang, Yan and Li, Xin and Li, Guang and Zheng, Zexin and Zhang, Lu and Feng, Xiaotian and Ma, Tiancheng and Chen, Yujing and Li, Yanxin and Liu, Yibo and Dong, Benchao and Yang, Peichuan and Li, Yan and Qin, Mengran and Ma, Jianxiong},
title = {Silk Fibroin‐Modified Titanium Implants for Bone Tissue Engineering: Structural Basis, Functionalization and Composite Strategies},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.70222}
}
EUVIMED